Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation in the United States.

The Dutch competitive and regulatory environment is benign compared with other European countries. The rational oligopoly structure in the broadband market should help to maintain stability. The Dutch ...